原料药行业滥用市场支配地位行为反垄断规制及其改进  

Anti Monopoly Regulation and Its Improvement on the Abuse of Market Dominance in the API Industry

作　　者：林逸玲 杨莉萍 LIN Yi-ling;YANG Li-ping(Law School of Fuzhou University,Fuzhou 350108,China)

机构地区：[1]福州大学法学院,福建福州350108

出　　处：《南京中医药大学学报（社会科学版）》2023年第4期239-247,共9页Journal of Nanjing University of Traditional Chinese Medicine(Social Science Edition)

基　　金：国家社会科学基金项目(20CFX052)。

摘　　要：原料药行业滥用市场支配地位的行为频频出现,呈现拒绝交易、不公平高价、搭售、附加不合理交易条件、限定交易行为等类型。究其原因,与制度特点、经济原因、药品行业的特殊属性密不可分。当前在原料药行业滥用市场支配地位行为的反垄断规制中,还面临着原料药行业的独家经销模式导致处罚对象争议大,原料药市场反垄断的处罚标准不明晰,甚至出现了反垄断处罚的逆向效应,即药价越来越高的困境。因此,主张依据竞争关系的性质对滥用市场支配地位行为的责任主体进行判定,防止相关责任主体规制逃逸;基于相关市场的范围对销售额的处罚标准进行厘定;放松对原料药市场准入的管制,以促进原料药市场竞争。The abuse of market dominance in the API industry frequently occurs,including refusal to trade,unfair high prices,tying,attaching unreasonable trading conditions,and restrictive trading behaviors.The reason for this is closely related to institutional characteristics,economic reasons,and the special attributes of the pharmaceutical industry.In the current solution to this problem,there is still a significant controversy over the punishment targets caused by the exclusive distribution model of the API industry.The punishment standards for antitrust in the API market are not clear,and even the reverse effect of antitrust punishment has emerged,namely the dilemma of increasing drug prices.Therefore,it is advocated to determine the responsible parties for the abuse of market dominance based on the nature of competitive relationships,in order to prevent relevant responsible parties from regulating and escaping;determine the penalty standard for sales based on the scope of relevant market;relax the regulation of market access for API to promote competition in the API market.

关 键 词：原料药行业 市场支配地位 反垄断逆向效应 处罚标准 

分 类 号：D922.294[政治法律—经济法学]